Eli Lilly
LLY
$746.74
Share price
-0.54%
Change (1 day)
100.55%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
EPS for Eli Lilly (LLY)
EPS in 2023 (TTM): $5.43
According to Eli Lilly's latest financial reports the company's current EPS (TTM) is $5.43. In 2022 the company made an earnings per share (EPS) of $6.82 an increase over its 2021 EPS that were of $6.05.
EPS history for Eli Lilly from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $5.43 | -20.38% |
| 2022 | $6.82 | 12.72% |
| 2021 | $6.05 | -9.74% |
| 2020 | $6.70 | -22.97% |
| 2019 | $8.70 | 180.31% |
| 2018 | $3.10 | -1733.89% |
| 2017 | -$0.19 | -107.39% |
| 2016 | $2.57 | 14.13% |
| 2015 | $2.25 | 1.67% |
| 2014 | $2.22 | -48.49% |
| 2013 | $4.30 | 18.12% |
| 2012 | $3.64 | -6.63% |
| 2011 | $3.90 | -14.85% |
| 2010 | $4.58 | 15.95% |
| 2009 | $3.95 | -308.99% |
| 2008 | -$1.89 | -169.74% |
| 2007 | $2.71 | 10.61% |
| 2006 | $2.45 | 34.62% |
| 2005 | $1.82 | 8.33% |
| 2004 | $1.68 | -29.41% |
| 2003 | $2.38 | -5.18% |
| 2002 | $2.51 | -3.09% |
| 2001 | $2.59 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 159.43% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -31.11% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -65.74% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -32.21% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 160.62% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | -41.42% | 🇫🇷 France |
 Merck MRK | $1.82 | -66.45% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -26.88% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -63.44% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $3.50 | -35.52% | 🇬🇧 UK |